These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29475064)

  • 1. Ursodeoxycholyl lysophosphatidylethanolamide negatively regulates TLR-mediated lipopolysaccharide response in human THP-1-derived macrophages.
    Horvatova A; Utaipan T; Otto AC; Zhang Y; Gan-Schreier H; Pavek P; Pathil A; Stremmel W; Chamulitrat W
    Eur J Pharmacol; 2018 Apr; 825():63-74. PubMed ID: 29475064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
    Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
    PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
    Pathil A; Warth A; Chamulitrat W; Stremmel W
    J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages.
    Ko WK; Lee SH; Kim SJ; Jo MJ; Kumar H; Han IB; Sohn S
    PLoS One; 2017; 12(6):e0180673. PubMed ID: 28665991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.
    Chamulitrat W; Burhenne J; Rehlen T; Pathil A; Stremmel W
    Hepatology; 2009 Jul; 50(1):143-54. PubMed ID: 19496180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice.
    Wang J; Deng X; Yi S; Pathil A; Zhang W; Setchell K; Stremmel W; Chamulitrat W
    Shock; 2015 Apr; 43(4):379-86. PubMed ID: 25526375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-Inflammatory Effect of Algae-Derived Lipid Extracts on Lipopolysaccharide (LPS)-Stimulated Human THP-1 Macrophages.
    Robertson RC; Guihéneuf F; Bahar B; Schmid M; Stengel DB; Fitzgerald GF; Ross RP; Stanton C
    Mar Drugs; 2015 Aug; 13(8):5402-24. PubMed ID: 26308008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
    Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
    Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against CD95/FAS-Induced Fulminant Hepatitis.
    Utaipan T; Otto AC; Gan-Schreier H; Chunglok W; Pathil A; Stremmel W; Chamulitrat W
    Shock; 2017 Aug; 48(2):251-259. PubMed ID: 28060213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different bile acid-phospholipid conjugates in acute hepatitis.
    Pathil A; Warth A; Chamulitrat W; Stremmel W
    Eur J Clin Invest; 2012 Feb; 42(2):130-8. PubMed ID: 21707612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
    Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
    Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages.
    Hu K; Yang Y; Tu Q; Luo Y; Ma R
    Eur J Pharmacol; 2013 Dec; 721(1-3):96-102. PubMed ID: 24104193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.
    Su J; Gan-Schreier H; Goeppert B; Chamulitrat W; Stremmel W; Pathil A
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.
    Harikrishnan H; Jantan I; Haque MA; Kumolosasi E
    BMC Complement Altern Med; 2018 Jul; 18(1):224. PubMed ID: 30045725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
    Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
    J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE
    Lee WS; Shin JS; Jang DS; Lee KT
    Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia/reperfusion injury via phospholipid metabolism-mediated mitochondrial quality control.
    Gu J; Zhang T; Guo J; Chen K; Wang G; Li H; Wang J
    FASEB J; 2020 May; 34(5):6198-6214. PubMed ID: 32162746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.